| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
132.54(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $539.68 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,506 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,439,266 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
5 |
6 |
7 |
8 |
| Total Sell Transactions |
6 |
8 |
10 |
15 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Todt Blair Williams |
EVP, CLO & CAO |
• – – |
2023-12-14 |
4 |
OE |
$311.48 |
$1,710,648 |
D/D |
5,492 |
18,004 |
|
- |
|
| Todt Blair Williams |
EVP, CLO & CAO |
• – – |
2023-12-01 |
4 |
D |
$483.12 |
$56,042 |
D/D |
(116) |
12,512 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2023-11-30 |
4 |
S |
$475.17 |
$501,304 |
D/D |
(1,055) |
1,787 |
|
-5% |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2023-10-24 |
4 |
S |
$454.35 |
$29,078 |
D/D |
(64) |
2,842 |
|
-10% |
|
| Kaye Mark |
EVP & CFO Designate |
• – – |
2023-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
20,276 |
20,276 |
|
- |
|
| Dixon Robert L Jr |
Director |
– • – |
2023-07-21 |
4 |
S |
$476.71 |
$147,780 |
D/D |
(310) |
9,638 |
|
0% |
|
| Dixon Robert L Jr |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
9,948 |
|
- |
|
| Neri Antonio F |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
3,936 |
|
- |
|
| Clark R Kerry |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
8,651 |
|
- |
|
| Peru Ramiro G |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
9,862 |
|
- |
|
| Hay Lewis III |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
10,518 |
|
- |
|
| Jallal Bahija |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
3,799 |
|
- |
|
| Tallett Elizebeth E |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
9,903 |
|
- |
|
| Devore Susan D. |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
1,313 |
|
- |
|
| Strable-Soethout Deanna D |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
657 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
457 |
5,611 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2023-03-24 |
4 |
AS |
$440.78 |
$6,714,978 |
D/D |
(15,098) |
51,435 |
|
2% |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2023-03-09 |
4 |
S |
$462.22 |
$1,069,577 |
D/D |
(2,314) |
15,327 |
|
-1% |
|
| Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
• – – |
2023-03-02 |
4 |
D |
$468.78 |
$2,563,758 |
D/D |
(5,469) |
17,893 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2023-03-02 |
4 |
D |
$468.78 |
$2,228,580 |
D/D |
(4,754) |
33,443 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2023-03-02 |
4 |
D |
$468.78 |
$2,545,475 |
D/D |
(5,430) |
66,533 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2023-03-02 |
4 |
D |
$468.78 |
$8,257,091 |
D/D |
(17,614) |
135,863 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2023-03-02 |
4 |
D |
$468.78 |
$178,136 |
D/D |
(380) |
2,882 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2023-03-02 |
4 |
D |
$468.78 |
$2,179,827 |
D/D |
(4,650) |
63,725 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2023-03-02 |
4 |
D |
$468.78 |
$508,158 |
D/D |
(1,084) |
17,641 |
|
- |
|
634 Records found
|
|
Page 2 of 26 |
|
|
1.35 (0.26%) 
